AARP: Specialty drug retail pricing escalates

September 8, 2017 by Chain Drug Review AARP, AARP Public Policy Institute, cost of generic drug therapy, cost of specialty drug therapy, Debra Whitman, generic drug price increases, Leigh Purvis, retail prices for specialty drugs Featured Articles, Leading Headlines, Pharmacy, Retail News

WASHINGTON — Retail prices for specialty drugs widely used by older Americans has surged, while pricing for generic drugs has dipped despite sharp hikes for some medications, according to a pair of new AARP Public Policy Institute (PPI) reports. For the specialty drugs examined in the study, retail prices jumped by an average of 9.6%